ULTRAGENYX’s Carolyn Wang on Rare Disease & Nurturing Patient Communities

Welcome to today's episode, where we're joined by Carolyn Wang, the SVP of Global Corporate Communications at Ultragenyx. With a rich background in life sciences that began at Elan Pharmaceuticals, Carolyn has been a key player in WCG's growth and has led BrewLife, a multi-million dollar agency. She’s also held a leadership role at Verily and currently serves on the board of the John Ritter Foundation for Aortic Health.

Today, we're delving into Carolyn's work at Ultragenyx, a game-changing company in the world of rare genetic diseases. We'll discuss their innovative approaches, such as broadening access to newborn screenings and hosting rare disease boot camps. We'll also explore the keys to nurturing patient communities and ensuring diversity in clinical trials and hear Carolyn's advice for those new to healthcare communications.

-----

Produced by Simpler Media